Brunswick (BC) Financials

$83.35 +2.39 (+2.95%)

Closing price 05/26/2026 03:58 PM Eastern

Extended Trading

$83.37 +0.02 (+0.02%)

As of 05:13 AM Eastern

Annual Income Statements for Brunswick

This table shows Brunswick's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	241	276	146	265	-131	373	593	677	420	130	-137
Consolidated Net Income / (Loss)	241	276	146	265	-131	373	593	677	420	130	-137
Net Income / (Loss) Continuing Operations	231	274	101	253	30	375	595	681	433	149	-136
Total Pre-Tax Income	315	390	213	311	111	473	736	854	629	203	-136
Total Operating Income	331	480	330	356	471	539	813	948	735	312	-41
Total Gross Profit	1,060	1,232	949	1,047	1,121	1,213	1,666	1,947	1,787	1,351	1,332
Total Revenue	3,780	4,489	3,802	4,121	4,108	4,348	5,846	6,812	6,401	5,237	5,363
Operating Revenue	3,780	4,489	3,802	4,121	4,108	4,348	5,846	6,812	6,401	5,237	5,363
Total Cost of Revenue	2,720	3,256	2,854	3,074	2,987	3,135	4,180	4,865	4,614	3,886	4,031
Operating Cost of Revenue	2,720	3,256	2,854	3,074	2,987	3,135	4,180	4,865	4,614	3,886	4,031
Total Operating Expenses	729	753	618	692	650	673	849	999	1,052	1,039	1,373
Selling, General & Admin Expense	528	598	458	515	510	544	698	771	812	748	851
Research & Development Expense	114	139	112	122	122	126	155	203	185	170	169
Impairment Charge	-	-	-	-	-	4.10	0.80	25	55	122	353
Restructuring Charge	4.70	16	49	55	19	0.00	-4.00	0.00	0.00	0.00	0.00
Other Special Charges / (Income)	82	-	-	0.00	-	-1.10	0.00	0.00	0.00	0.00	0.00
Total Other Income / (Expense), net	-17	-90	-117	-45	-360	-68	-73	-94	-106	-108	-95
Interest Expense	28	28	26	51	76	67	70	98	112	139	108
Interest & Investment Income	5.90	6.10	8.70	11	11	5.70	4.40	10	-1.20	22	14
Other Income / (Expense), net	5.30	-68	-100	-4.30	-295	-6.10	-6.80	-6.10	7.60	9.00	-1.60
Income Tax Expense	84	115	112	57	80	98	141	172	196	54	0.20
Net Income / (Loss) Discontinued Operations	11	1.60	45	12	-161	-2.00	-2.10	-4.30	-12	-19	-1.40
Basic Earnings per Share	$2.60	$3.03	$1.64	$3.03	($1.54)	$4.70	$7.63	$9.05	$5.99	$1.94	($2.08)
Weighted Average Basic Shares Outstanding	93M	91.20M	89.40M	87.60M	85.20M	79.20M	77.80M	74.80M	70.20M	67.20M	65.90M
Diluted Earnings per Share	$2.56	$3.00	$1.62	$3.01	($1.53)	$4.68	$7.57	$9.00	$5.96	$1.93	($2.08)
Weighted Average Diluted Shares Outstanding	94.30M	92M	90.10M	88.20M	85.60M	79.70M	78.40M	75.20M	70.50M	67.40M	65.90M
Weighted Average Basic & Diluted Shares Outstanding	92.80M	91.10M	89.30M	87.60M	79.47M	153.13M	153.13M	142.30M	136.34M	65.84M	64.85M
Cash Dividends to Common per Share	$0.53	$0.62	$0.69	$0.78	$0.87	$0.99	$1.28	$1.46	$1.60	$1.68	$1.72

This table shows Brunswick's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/30/2024	6/29/2024	9/28/2024	12/31/2024	3/29/2025	6/28/2025	9/27/2025	12/31/2025	4/4/2026
Net Income / (Loss) Attributable to Common Shareholders	113	61	68	100	45	-83	24	59	-236	19	21
Consolidated Net Income / (Loss)	113	61	68	100	45	-83	20	59	-236	19	21
Net Income / (Loss) Continuing Operations	114	71	68	105	47	-71	0.00	60	-234	19	21
Total Pre-Tax Income	160	86	87	133	70	-86	28	75	-266	27	27
Total Operating Income	196	108	111	158	98	-56	56	103	-242	42	50
Total Gross Profit	445	364	374	391	333	253	304	370	351	308	344
Total Revenue	1,594	1,362	1,365	1,444	1,273	1,155	1,222	1,447	1,360	1,334	1,378
Operating Revenue	1,594	1,362	1,365	1,444	1,273	1,155	1,222	1,447	1,360	1,334	1,378
Total Cost of Revenue	1,149	998	991	1,053	940	902	918	1,077	1,009	1,026	1,035
Operating Cost of Revenue	1,149	998	991	1,053	940	902	918	1,077	1,009	1,026	1,035
Total Operating Expenses	249	256	263	233	235	309	248	266	593	266	293
Selling, General & Admin Expense	187	199	204	182	181	182	208	217	216	211	242
Research & Development Expense	45	42	46	43	42	39	39	42	43	45	46
Impairment Charge	16	15	14	7.90	12	88	-	8.00	334	10	4.80
Restructuring Charge	0.00	-	0.00	0.00	0.00	-	1.10	0.00	0.00	-	0.00
Total Other Income / (Expense), net	-36	-23	-24	-26	-29	-30	-25	-28	-24	-15	-23
Interest Expense	28	27	29	33	33	45	30	30	27	17	25
Interest & Investment Income	-14	4.10	5.00	7.60	5.60	3.80	3.90	3.40	3.30	3.60	2.80
Other Income / (Expense), net	6.00	0.70	0.00	-0.80	-1.10	11	1.30	-1.40	-0.40	-1.10	-1.60
Income Tax Expense	46	15	19	28	23	-15	7.90	16	-32	8.60	5.90
Net Income / (Loss) Discontinued Operations	-1.40	-10	-0.40	-4.80	-2.70	-11	0.00	-0.30	-1.20	0.10	0.00
Basic Earnings per Share	$1.61	$0.91	$0.99	$1.48	$0.67	($1.20)	$0.31	$0.89	($3.59)	$0.31	$0.32
Weighted Average Basic Shares Outstanding	69.80M	70.20M	68.30M	67.60M	66.60M	67.20M	66.20M	66M	65.70M	65.90M	65.40M
Diluted Earnings per Share	$1.61	$0.89	$0.99	$1.48	$0.67	($1.21)	$0.30	$0.89	($3.59)	$0.32	$0.32
Weighted Average Diluted Shares Outstanding	70M	70.50M	68.50M	67.60M	66.60M	67.40M	66.30M	66M	65.70M	65.90M	65.70M
Weighted Average Basic & Diluted Shares Outstanding	137.63M	136.34M	67.57M	132.45M	65.98M	65.84M	65.68M	65.33M	65.04M	64.85M	64.97M
Cash Dividends to Common per Share	$0.40	-	$0.42	$0.00	$0.00	-	$0.43	$0.00	$0.00	-	$0.44

This table details how cash moves in and out of Brunswick's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	102	-236	25	471	29	198	-164	169	-130	-193	-11
Net Cash From Operating Activities	331	435	400	337	434	798	574	586	734	431	562
Net Cash From Continuing Operating Activities	340	439	308	275	475	800	586	580	745	450	586
Net Income / (Loss) Continuing Operations	231	274	101	253	30	375	595	681	433	149	-136
Consolidated Net Income / (Loss)	241	276	146	265	-131	373	593	677	420	130	-137
Net Income / (Loss) Discontinued Operations	11	1.60	45	12	-161	-2.00	-2.10	-4.30	-12	-19	-1.40
Depreciation Expense	77	104	87	124	139	153	178	231	273	289	293
Non-Cash Adjustments To Reconcile Net Income	46	14	86	-107	314	25	28	41	61	115	280
Changes in Operating Assets and Liabilities, net	-14	47	34	4.40	-7.40	247	-216	-373	-21	-104	149
Net Cash From Discontinued Operating Activities	-9.70	-3.80	92	63	-41	-1.70	-12	5.70	-12	-18	-24
Net Cash From Investing Activities	-43	-486	-179	-1,107	195	-247	-1,354	-443	-379	-169	-142
Net Cash From Continuing Investing Activities	-69	-486	-154	-1,098	-287	-239	0.00	0.00	0.00	0.00	0.00
Purchase of Property, Plant & Equipment	-114	-194	-178	-180	-233	-182	-267	-388	-289	-167	-166
Acquisitions	-30	-276	-16	-910	-64	0.00	-1,139	-94	-104	-32	-0.20
Purchase of Investments	-48	-35	-3.20	-8.80	0.00	-56	0.00	-71	-4.60	-81	0.00
Sale of Property, Plant & Equipment	2.40	1.90	7.90	0.40	7.30	2.90	7.20	11	15	15	13
Divestitures	-	-	-	-	-	-	-	0.00	0.00	9.50	0.40
Sale and/or Maturity of Investments	120	16	35	-	2.40	-4.00	45	56	3.80	85	6.50
Other Investing Activities, net	0.00	1.30	0.00	-0.20	0.00	0.00	0.00	-43	0.00	-1.70	4.90
Net Cash From Discontinued Investing Activities	26	-	-25	-8.90	482	-7.50	0.00	0.00	0.00	0.00	0.00
Net Cash From Financing Activities	-171	-186	-204	1,241	-601	-362	622	111	-487	-443	-441
Net Cash From Continuing Financing Activities	-176	-186	-202	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Repayment of Debt	-3.10	-5.10	-3.00	-319	-997	-769	-140	-188	-82	-632	-414
Repurchase of Common Equity	-120	-120	-130	-75	-400	-118	-120	-450	-275	-200	-80
Payment of Dividends	-48	-55	-61	-68	-73	-78	-99	-109	-112	-112	-113
Issuance of Debt	0.10	1.00	0.00	1,094	879	610	994	874	-3.90	511	173
Issuance of Common Equity	4.50	15	6.20	1.40	2.80	1.50	0.00	0.00	0.00	0.00	0.00
Other Financing Activities, net	-8.70	-21	-15	-633	-12	-7.70	-14	-16	-14	-9.30	-7.40
Effect of Exchange Rate Changes	-16	0.10	6.90	-	0.40	8.80	-5.50	-	2.70	-13	9.70
Cash Interest Paid	29	30	33	47	80	73	73	95	117	140	115
Cash Income Taxes Paid	-	-	-	22	18	112	147	197	175	94	48

This table details how cash moves in and out of Brunswick's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/30/2024	6/29/2024	9/28/2024	12/31/2024	3/29/2025	6/28/2025	9/27/2025	12/31/2025	4/4/2026
Net Change in Cash & Equivalents	-147	137	81	-49	-210	-15	7.60	29	-18	-41	14
Net Cash From Operating Activities	198	283	-153	211	67	306	-27	316	140	133	-64
Net Cash From Continuing Operating Activities	204	287	-148	216	70	312	-13	323	142	135	-64
Net Income / (Loss) Continuing Operations	114	71	68	105	47	-71	0.00	60	-234	19	21
Consolidated Net Income / (Loss)	113	61	68	100	45	-83	20	59	-236	19	21
Net Income / (Loss) Discontinued Operations	-1.40	-10	-0.40	-4.80	-2.70	-11	0.00	-0.30	-1.20	0.10	0.00
Depreciation Expense	69	72	69	70	72	77	70	73	74	76	75
Non-Cash Adjustments To Reconcile Net Income	25	22	6.60	10	10	89	6.80	11	334	-71	10
Changes in Operating Assets and Liabilities, net	-4.70	123	-293	31	-60	218	-111	179	-31	112	-170
Net Cash From Discontinued Operating Activities	-5.50	-3.80	-5.30	-4.70	-2.50	-5.60	-14	-6.30	-1.60	-1.70	-0.40
Net Cash From Investing Activities	-140	-69	-55	-121	22	-15	-35	-35	-28	-44	-55
Net Cash From Continuing Investing Activities	-140	310	-55	-121	22	154	-39	-35	-28	98	-55
Purchase of Property, Plant & Equipment	-60	-56	-54	-47	-36	-30	-38	-45	-34	-49	-57
Acquisitions	-90	-14	-0.70	0.10	-31	-	0.00	-	-0.20	-	0.00
Purchase of Investments	4.80	-3.00	-3.00	-77	4.30	-2.60	-2.80	3.30	4.60	-5.10	-2.70
Sale of Property, Plant & Equipment	4.30	4.20	2.30	3.10	2.80	6.80	3.40	3.40	2.00	3.80	4.70
Sale and/or Maturity of Investments	-	-	0.00	-	82	-	0.00	-	-	6.50	0.00
Other Investing Activities, net	-	-	0.00	-	-	1.70	-2.10	3.20	-	-0.40	0.00
Net Cash From Financing Activities	-199	-84	294	-137	-304	-296	78	-259	-132	-128	134
Net Cash From Continuing Financing Activities	-199	403	294	-137	-304	147	74	-259	-132	313	134
Repayment of Debt	-84	-3.70	-2.50	-2.50	-456	-258	-131	-214	-107	35	-1.20
Repurchase of Common Equity	-88	-55	-64	-106	-20	-10	-26	-18	-22	-15	-16
Payment of Dividends	-28	-27	-29	-28	-28	-28	-28	-28	-28	-28	-29
Issuance of Debt	0.70	2.40	398	0.20	200	0.30	266	1.40	25	-120	195
Issuance of Common Equity	-	-	0.00	-	-	-	0.00	-	-	-	0.00
Other Financing Activities, net	-	-0.40	-9.20	-	-0.10	-	-6.90	-0.20	-0.20	-0.10	-15
Effect of Exchange Rate Changes	-5.60	6.70	-4.70	-2.30	5.00	-11	-	6.90	1.00	-1.50	-0.60
Cash Interest Paid	-	-	-	-	-	-	46	-	-	-	42
Cash Income Taxes Paid	-	-	-	-	-	-	2.60	-	-	-	17

This table presents Brunswick's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	3,153	3,285	3,358	4,292	3,564	3,771	5,425	6,321	6,231	5,678	5,312
Total Current Assets	1,804	1,689	1,847	1,880	1,526	1,671	2,125	2,695	2,510	2,114	2,063
Cash & Equivalents	657	422	449	294	320	520	355	596	468	269	257
Restricted Cash	13	11	9.40	9.00	12	11	12	13	11	17	18
Short-Term Investments	12	36	0.80	0.80	0.80	57	0.80	4.50	0.80	0.80	0.80
Accounts Receivable	398	412	485	352	332	338	485	543	493	429	512
Inventories, net	685	699	828	774	825	712	1,208	1,471	1,477	1,303	1,192
Prepaid Expenses	40	37	75	73	37	34	64	68	60	96	73
Plant, Property, & Equipment, net	505	569	706	695	796	864	1,047	1,271	1,316	1,252	1,208
Plant, Property & Equipment, gross	1,367	1,346	1,602	1,486	1,660	1,793	2,037	2,322	2,451	2,438	2,499
Accumulated Depreciation	861	777	896	792	864	930	990	1,051	1,136	1,187	1,291
Total Noncurrent Assets	843	1,027	806	1,717	1,242	1,237	2,254	2,355	2,405	2,312	2,041
Long-Term Investments	22	21	25	33	30	33	44	54	39	35	34
Goodwill	299	414	425	377	415	418	888	968	1,031	966	681
Intangible Assets	55	160	149	586	584	552	1,052	997	978	918	855
Noncurrent Deferred & Refundable Income Taxes	420	308	166	98	119	137	146	203	187	198	272
Other Noncurrent Operating Assets	47	43	40	13	96	97	123	133	171	196	199
Total Liabilities & Shareholders' Equity	3,153	3,285	3,358	4,292	3,564	3,771	5,425	6,321	6,231	5,678	5,312
Total Liabilities	1,871	1,845	1,875	2,709	2,264	2,261	3,511	4,279	4,143	3,785	3,687
Total Current Liabilities	908	965	1,035	1,257	944	1,079	1,442	1,490	1,752	1,280	1,429
Short-Term Debt	6.00	5.60	5.60	41	41	43	37	89	455	243	295
Accounts Payable	339	378	421	458	394	458	694	663	558	393	375
Accrued Expenses	563	521	609	502	510	579	711	738	739	644	758
Total Noncurrent Liabilities	963	880	840	1,452	1,319	1,181	2,069	2,789	2,391	2,506	2,258
Long-Term Debt	443	434	432	1,180	1,068	908	1,779	2,420	1,976	2,098	1,807
Noncurrent Deferred & Payable Income Tax Liabilities	12	-	-	-	-	-	3.10	61	12	10	10
Noncurrent Employee Benefit Liabilities	348	276	221	72	74	75	67	50	53	46	38
Other Noncurrent Operating Liabilities	161	163	188	102	178	198	220	259	350	351	403
Total Equity & Noncontrolling Interests	1,281	1,440	1,483	1,583	1,301	1,510	1,914	2,042	2,087	1,892	1,626
Total Preferred & Common Equity	1,281	1,440	1,483	1,583	1,301	1,467	1,914	2,042	2,087	1,892	1,626
Total Common Equity	1,281	1,440	1,483	1,583	1,301	1,467	1,914	2,042	2,087	1,892	1,626
Common Stock	485	459	451	448	446	461	471	468	469	479	504
Retained Earnings	1,660	1,881	1,967	2,136	1,931	2,226	2,720	3,289	3,597	3,615	3,365
Treasury Stock	-390	-465	-575	-638	-1,023	-1,134	-1,246	-1,685	-1,953	-2,148	-2,220
Accumulated Other Comprehensive Income / (Loss)	-474	-435	-360	-363	-53	-85	-32	-30	-26	-53	-23

This table presents Brunswick's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	10/1/2022	4/1/2023	7/1/2023	9/30/2023	3/30/2024	6/29/2024	9/28/2024	3/29/2025	6/28/2025	9/27/2025	4/4/2026
Total Assets	6,125	6,289	6,290	6,101	6,509	6,396	6,024	5,857	5,794	5,414	5,506
Total Current Assets	2,595	2,678	2,673	2,441	2,807	2,728	2,348	2,306	2,236	2,158	2,286
Cash & Equivalents	457	388	478	331	548	495	284	287	316	298	278
Restricted Cash	12	11	11	11	11	16	17	18	18	18	11
Short-Term Investments	35	0.80	0.80	0.80	0.80	83	0.80	0.80	0.80	0.80	0.80
Accounts Receivable	558	698	615	568	617	530	501	553	510	491	639
Inventories, net	1,430	1,506	1,484	1,445	1,555	1,524	1,465	1,354	1,305	1,273	1,254
Prepaid Expenses	104	75	85	85	75	81	81	94	87	77	105
Plant, Property, & Equipment, net	1,221	1,294	1,314	1,312	1,309	1,300	1,278	1,240	1,239	1,218	1,193
Plant, Property & Equipment, gross	2,252	2,368	2,409	2,423	2,463	2,477	2,478	2,454	2,483	2,494	2,510
Accumulated Depreciation	1,031	1,074	1,095	1,111	1,154	1,177	1,199	1,214	1,245	1,277	1,316
Total Noncurrent Assets	2,309	2,317	2,303	2,348	2,393	2,367	2,397	2,312	2,320	2,038	2,026
Long-Term Investments	48	62	60	36	41	38	33	38	35	31	37
Goodwill	962	974	975	1,008	1,026	1,024	1,060	973	986	680	676
Intangible Assets	1,005	992	979	1,000	964	948	940	910	899	866	843
Noncurrent Deferred & Refundable Income Taxes	138	148	150	151	186	187	187	198	207	258	272
Other Noncurrent Operating Assets	156	141	139	154	175	171	178	192	192	204	198
Total Liabilities & Shareholders' Equity	6,125	6,289	6,290	6,101	6,509	6,396	6,024	5,857	5,794	5,414	5,506
Total Liabilities	4,124	4,226	4,189	4,015	4,459	4,382	3,989	3,985	3,889	3,780	3,904
Total Current Liabilities	1,379	1,439	1,394	1,659	1,674	1,608	1,194	1,468	1,334	1,215	1,662
Short-Term Debt	85	90	88	455	455	455	199	386	177	96	490
Accounts Payable	632	594	549	493	514	448	369	420	423	413	460
Accrued Expenses	663	755	756	711	705	706	626	662	735	706	711
Total Noncurrent Liabilities	2,745	2,788	2,795	2,356	2,785	2,774	2,795	2,517	2,555	2,565	2,243
Long-Term Debt	2,419	2,421	2,422	1,976	2,372	2,372	2,373	2,098	2,098	2,097	1,806
Noncurrent Deferred & Payable Income Tax Liabilities	2.60	12	13	12	12	12	12	10	11	11	9.90
Noncurrent Employee Benefit Liabilities	63	48	47	46	50	49	49	46	47	45	38
Other Noncurrent Operating Liabilities	260	306	313	322	352	341	361	363	399	411	389
Total Equity & Noncontrolling Interests	2,001	2,063	2,101	2,086	2,050	2,014	2,034	1,872	1,905	1,634	1,602
Total Preferred & Common Equity	2,001	2,063	2,101	2,086	2,050	2,014	2,034	1,872	1,905	1,634	1,602
Total Common Equity	2,001	2,063	2,101	2,086	2,050	2,014	2,034	1,872	1,905	1,634	1,602
Common Stock	463	453	461	462	460	466	475	473	483	493	487
Retained Earnings	3,173	3,372	3,479	3,563	3,636	3,708	3,725	3,607	3,638	3,374	3,357
Treasury Stock	-1,595	-1,737	-1,809	-1,898	-2,011	-2,118	-2,138	-2,167	-2,184	-2,205	-2,225
Accumulated Other Comprehensive Income / (Loss)	-40	-26	-29	-42	-36	-43	-28	-41	-32	-28	-18

This table displays calculated financial ratios and metrics derived from Brunswick's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-1.52%	18.74%	-15.29%	8.38%	-0.30%	5.82%	34.47%	16.52%	-6.03%	-18.19%	2.40%
EBITDA Growth	-0.60%	24.49%	-38.31%	49.58%	-33.75%	118.11%	43.34%	19.17%	-13.43%	-39.98%	-58.94%
EBIT Growth	0.48%	22.13%	-43.91%	52.30%	-49.86%	202.78%	51.18%	16.82%	-21.15%	-56.82%	-113.19%
NOPAT Growth	9.27%	38.94%	-53.45%	84.49%	-55.39%	230.51%	53.75%	15.10%	-33.18%	-54.73%	-112.45%
Net Income Growth	-1.75%	14.33%	-46.96%	81.22%	-149.38%	384.50%	59.19%	14.11%	-37.90%	-69.05%	-205.53%
EPS Growth	-0.78%	17.19%	-46.00%	85.80%	-150.83%	405.88%	61.75%	18.89%	-33.78%	-67.62%	-207.77%
Operating Cash Flow Growth	33.16%	31.71%	-8.04%	-15.81%	28.84%	83.86%	-28.10%	2.11%	25.17%	-41.19%	30.30%
Free Cash Flow Firm Growth	-19.75%	-59.13%	-61.00%	-548.92%	21.02%	845.79%	-229.44%	123.35%	103.89%	-18.80%	46.68%
Invested Capital Growth	9.92%	26.90%	10.22%	27.68%	11.69%	-10.06%	80.21%	17.02%	2.96%	-2.21%	-12.62%
Revenue Q/Q Growth	-6.85%	10.39%	-18.38%	13.50%	5.14%	5.93%	4.84%	2.28%	-3.33%	0.00%	3.45%
EBITDA Q/Q Growth	-11.94%	16.15%	-39.58%	109.71%	5.39%	-15.88%	23.41%	7.37%	-6.41%	0.00%	50.90%
EBIT Q/Q Growth	-11.58%	15.61%	-44.53%	155.98%	10.96%	-20.24%	28.63%	7.71%	-9.48%	0.00%	66.93%
NOPAT Q/Q Growth	-5.73%	27.03%	-55.86%	186.24%	458.33%	-25.02%	32.23%	6.03%	-12.97%	0.00%	70.57%
Net Income Q/Q Growth	-2.03%	10.84%	-47.90%	152.67%	15.32%	7.78%	1.28%	6.31%	-16.12%	0.00%	42.43%
EPS Q/Q Growth	-1.92%	11.11%	-47.91%	144.72%	17.30%	9.09%	1.34%	7.91%	-15.22%	0.00%	42.38%
Operating Cash Flow Q/Q Growth	-4.73%	10.74%	0.03%	-11.20%	35.99%	-7.04%	-7.72%	39.28%	1.19%	5.66%	-23.59%
Free Cash Flow Firm Q/Q Growth	-40.99%	160.51%	-87.28%	0.51%	77.78%	-27.95%	-531.95%	117.42%	-1.45%	0.00%	-33.05%
Invested Capital Q/Q Growth	-2.45%	-8.23%	-9.54%	2.04%	-4.45%	0.43%	55.02%	-1.76%	-3.36%	0.00%	-1.80%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	28.04%	27.46%	24.95%	25.41%	27.29%	27.90%	28.50%	28.58%	27.92%	25.79%	24.84%
EBITDA Margin	10.94%	11.47%	8.36%	11.53%	7.66%	15.79%	16.83%	17.22%	15.86%	11.64%	4.67%
Operating Margin	8.76%	10.68%	8.69%	8.63%	11.46%	12.40%	13.90%	13.91%	11.48%	5.95%	-0.76%
EBIT Margin	8.90%	9.16%	6.06%	8.52%	4.29%	12.26%	13.79%	13.82%	11.60%	6.12%	-0.79%
Profit (Net Income) Margin	6.39%	6.15%	3.85%	6.44%	-3.19%	8.57%	10.15%	9.94%	6.57%	2.48%	-2.56%
Tax Burden Percent	76.68%	70.82%	68.76%	85.39%	-118.34%	78.84%	80.57%	79.31%	66.85%	63.99%	101.18%
Interest Burden Percent	93.52%	94.79%	92.32%	88.47%	62.86%	88.65%	91.35%	90.64%	84.70%	63.41%	320.80%
Effective Tax Rate	26.65%	29.59%	52.42%	18.44%	72.54%	20.73%	19.15%	20.19%	31.21%	26.56%	0.00%
Return on Invested Capital (ROIC)	24.78%	28.98%	11.47%	17.73%	6.66%	21.98%	25.47%	21.00%	12.82%	5.79%	-0.78%
ROIC Less NNEP Spread (ROIC-NNEP)	25.44%	60.46%	23.18%	-6.37%	-45.50%	11.82%	18.11%	16.11%	8.29%	0.76%	-6.49%
Return on Net Nonoperating Assets (RNNOA)	-5.10%	-8.70%	-1.46%	-0.43%	-15.75%	4.54%	9.18%	13.22%	7.54%	0.75%	-7.03%
Return on Equity (ROE)	19.68%	20.28%	10.02%	17.31%	-9.09%	26.52%	34.65%	34.22%	20.36%	6.54%	-7.81%
Cash Return on Invested Capital (CROIC)	15.33%	5.27%	1.75%	-6.58%	-4.38%	32.58%	-31.78%	5.32%	9.90%	8.02%	12.69%
Operating Return on Assets (OROA)	10.71%	12.77%	6.94%	9.18%	4.48%	14.54%	17.53%	16.03%	11.83%	5.38%	-0.77%
Return on Assets (ROA)	7.68%	8.58%	4.41%	6.94%	-3.34%	10.16%	12.90%	11.53%	6.70%	2.19%	-2.50%
Return on Common Equity (ROCE)	19.68%	20.28%	10.02%	17.31%	-9.09%	26.12%	34.22%	34.22%	20.36%	6.54%	-7.81%
Return on Equity Simple (ROE_SIMPLE)	18.84%	19.17%	9.87%	16.76%	-10.07%	25.40%	30.99%	33.15%	20.14%	6.88%	0.00%
Net Operating Profit after Tax (NOPAT)	243	338	157	290	129	427	657	756	506	229	-28
NOPAT Margin	6.43%	7.52%	4.13%	7.04%	3.15%	9.83%	11.24%	11.10%	7.90%	4.37%	-0.53%
Net Nonoperating Expense Percent (NNEP)	-0.65%	-31.48%	-11.71%	24.11%	52.16%	10.16%	7.36%	4.90%	4.53%	5.02%	5.71%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	16.62%	11.19%	5.41%	-0.76%
Cost of Revenue to Revenue	71.96%	72.54%	75.05%	74.59%	72.71%	72.10%	71.50%	71.42%	72.08%	74.21%	75.16%
SG&A Expenses to Revenue	13.96%	13.33%	12.05%	12.50%	12.40%	12.51%	11.94%	11.32%	12.69%	14.28%	15.87%
R&D to Revenue	3.01%	3.10%	2.94%	2.95%	2.96%	2.90%	2.64%	2.98%	2.89%	3.24%	3.15%
Operating Expenses to Revenue	19.28%	16.77%	16.26%	16.78%	15.82%	15.47%	14.52%	14.67%	16.44%	19.84%	25.60%
Earnings before Interest and Taxes (EBIT)	337	411	231	351	176	533	806	942	743	321	-42
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	414	515	318	475	315	687	984	1,173	1,015	609	250
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.11	2.99	2.91	2.30	3.45	3.80	3.83	2.46	3.12	2.26	2.97
Price to Tangible Book Value (P/TBV)	4.30	4.96	4.74	5.87	14.85	11.20	0.00	64.94	82.87	540.23	53.89
Price to Revenue (P/Rev)	1.05	0.96	1.13	0.88	1.09	1.28	1.25	0.74	1.02	0.81	0.90
Price to Earnings (P/E)	16.52	15.58	29.44	13.70	0.00	14.94	12.36	7.41	15.51	32.80	0.00
Dividend Yield	1.20%	1.28%	1.39%	1.86%	1.58%	1.39%	1.34%	2.64%	1.69%	2.60%	2.32%
Earnings Yield	6.05%	6.42%	3.40%	7.30%	0.00%	6.69%	8.09%	13.49%	6.45%	3.05%	0.00%
Enterprise Value to Invested Capital (EV/IC)	3.64	3.26	2.97	2.46	2.56	3.20	2.63	1.77	2.11	1.61	1.94
Enterprise Value to Revenue (EV/Rev)	0.99	0.95	1.12	1.10	1.27	1.36	1.49	1.01	1.32	1.20	1.23
Enterprise Value to EBITDA (EV/EBITDA)	9.02	8.25	13.42	9.51	16.63	8.59	8.88	5.85	8.31	10.32	26.46
Enterprise Value to EBIT (EV/EBIT)	11.09	10.33	18.49	12.86	29.73	11.07	10.84	7.29	11.36	19.61	0.00
Enterprise Value to NOPAT (EV/NOPAT)	15.36	12.58	27.12	15.58	40.48	13.80	13.30	9.07	16.68	27.47	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	11.29	9.76	10.65	13.40	12.06	7.39	15.22	11.71	11.50	14.57	11.78
Enterprise Value to Free Cash Flow (EV/FCFF)	24.83	69.15	177.92	0.00	0.00	9.31	0.00	35.83	21.60	19.83	14.24
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.35	0.31	0.30	0.77	0.85	0.63	0.95	1.23	1.16	1.24	1.29
Long-Term Debt to Equity	0.35	0.30	0.29	0.75	0.82	0.60	0.93	1.18	0.95	1.11	1.11
Financial Leverage	-0.20	-0.14	-0.06	0.07	0.35	0.38	0.51	0.82	0.91	0.99	1.08
Leverage Ratio	2.56	2.37	2.27	2.50	2.72	2.61	2.69	2.97	3.04	2.99	3.12
Compound Leverage Factor	2.40	2.24	2.10	2.21	1.71	2.31	2.45	2.69	2.57	1.90	10.02
Debt to Total Capital	25.93%	23.38%	22.78%	43.55%	46.03%	38.65%	48.69%	55.13%	53.80%	55.30%	56.39%
Short-Term Debt to Total Capital	0.35%	0.30%	0.29%	1.47%	1.71%	1.75%	1.00%	1.96%	10.06%	5.74%	7.92%
Long-Term Debt to Total Capital	25.58%	23.08%	22.49%	42.07%	44.31%	36.90%	47.69%	53.17%	43.73%	49.56%	48.47%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	74.07%	76.62%	77.22%	56.45%	53.97%	59.61%	51.31%	44.87%	46.20%	44.70%	43.61%
Debt to EBITDA	1.08	0.85	1.38	2.57	3.52	1.39	1.85	2.14	2.39	3.84	8.40
Net Debt to EBITDA	-0.62	-0.10	-0.15	1.86	2.37	0.48	1.43	1.57	1.88	3.31	7.16
Long-Term Debt to EBITDA	1.07	0.84	1.36	2.48	3.39	1.32	1.81	2.06	1.95	3.44	7.22
Debt to NOPAT	1.85	1.30	2.78	4.21	8.58	2.23	2.76	3.32	4.81	10.23	-73.79
Net Debt to NOPAT	-1.05	-0.15	-0.30	3.05	5.78	0.78	2.14	2.43	3.78	8.82	-62.90
Long-Term Debt to NOPAT	1.82	1.28	2.75	4.07	8.26	2.12	2.71	3.20	3.91	9.17	-63.42
Altman Z-Score	3.91	4.24	3.85	2.91	3.46	4.11	3.67	3.23	3.32	2.85	2.80
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	1.52%	1.25%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.99	1.75	1.78	1.50	1.62	1.55	1.47	1.81	1.43	1.65	1.44
Quick Ratio	1.17	0.90	0.90	0.51	0.69	0.85	0.58	0.77	0.55	0.55	0.55
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	150	61	24	-108	-85	634	-820	191	390	317	465
Operating Cash Flow to CapEx	295.88%	226.72%	235.33%	187.43%	192.72%	444.74%	220.85%	155.46%	267.25%	283.07%	366.91%
Free Cash Flow to Firm to Interest Expense	5.43	2.23	0.91	-2.10	-1.12	9.41	-11.70	1.95	3.47	2.28	4.32
Operating Cash Flow to Interest Expense	11.93	15.83	15.16	6.59	5.71	11.86	8.19	5.97	6.53	3.10	5.22
Operating Cash Flow Less CapEx to Interest Expense	7.90	8.85	8.72	3.08	2.75	9.19	4.48	2.13	4.08	2.00	3.80
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.20	1.39	1.14	1.08	1.05	1.19	1.27	1.16	1.02	0.88	0.98
Accounts Receivable Turnover	9.64	11.09	8.48	9.85	12.02	12.99	14.21	13.25	12.36	11.36	11.27
Inventory Turnover	4.07	4.71	3.74	3.84	3.74	4.08	4.35	3.63	3.13	2.80	3.23
Fixed Asset Turnover	7.83	8.36	5.96	5.88	5.51	5.24	6.12	5.88	4.95	4.08	4.36
Accounts Payable Turnover	8.29	9.08	7.15	7.00	7.02	7.37	7.26	7.18	7.56	8.17	10.49
Days Sales Outstanding (DSO)	37.88	32.92	43.05	37.07	30.37	28.10	25.69	27.55	29.54	32.14	32.39
Days Inventory Outstanding (DIO)	89.72	77.57	97.64	95.09	97.65	89.45	83.82	100.51	116.60	130.52	112.97
Days Payable Outstanding (DPO)	44.05	40.20	51.08	52.17	52.03	49.55	50.26	50.87	48.27	44.68	34.79
Cash Conversion Cycle (CCC)	83.55	70.29	89.60	80.00	75.99	67.99	59.25	77.19	97.87	117.98	110.57
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,027	1,303	1,436	1,834	2,048	1,842	3,319	3,884	3,999	3,911	3,418
Invested Capital Turnover	3.86	3.85	2.78	2.52	2.12	2.24	2.27	1.89	1.62	1.32	1.46
Increase / (Decrease) in Invested Capital	93	276	133	398	214	-206	1,477	565	115	-88	-494
Enterprise Value (EV)	3,733	4,248	4,263	4,517	5,236	5,901	8,738	6,862	8,434	6,287	6,620
Market Capitalization	3,987	4,299	4,310	3,633	4,489	5,569	7,333	5,020	6,522	4,268	4,828
Book Value per Share	$14.07	$16.06	$16.91	$18.25	$15.95	$18.73	$24.83	$28.17	$30.33	$28.68	$25.00
Tangible Book Value per Share	$10.19	$9.66	$10.36	$7.14	$3.71	$6.35	($0.34)	$1.07	$1.14	$0.12	$1.38
Total Capital	1,730	1,880	1,920	2,803	2,410	2,461	3,731	4,551	4,518	4,233	3,728
Total Debt	449	439	437	1,221	1,109	951	1,816	2,509	2,430	2,341	2,102
Total Long-Term Debt	443	434	432	1,180	1,068	908	1,779	2,420	1,976	2,098	1,807
Net Debt	-255	-51	-47	884	747	332	1,405	1,842	1,912	2,019	1,792
Capital Expenditures (CapEx)	112	192	170	180	225	180	260	377	275	152	153
Debt-free, Cash-free Net Working Capital (DFCFNWC)	221	260	358	361	290	47	352	681	733	790	654
Debt-free Net Working Capital (DFNWC)	902	729	817	665	623	634	720	1,294	1,212	1,077	930
Net Working Capital (NWC)	896	724	812	624	581	591	682	1,205	758	834	635
Net Nonoperating Expense (NNE)	1.60	62	11	25	260	55	64	79	85	99	109
Net Nonoperating Obligations (NNO)	-255	-137	-47	251	747	332	1,405	1,842	1,912	2,019	1,792
Total Depreciation and Amortization (D&A)	77	104	87	124	139	153	178	231	273	289	293
Debt-free, Cash-free Net Working Capital to Revenue	5.84%	5.79%	9.42%	8.75%	7.06%	1.09%	6.03%	10.00%	11.44%	15.08%	12.20%
Debt-free Net Working Capital to Revenue	23.87%	16.25%	21.49%	16.13%	15.16%	14.59%	12.31%	19.00%	18.94%	20.56%	17.34%
Net Working Capital to Revenue	23.71%	16.12%	21.35%	15.13%	14.15%	13.60%	11.67%	17.69%	11.83%	15.92%	11.83%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.60	$3.03	$1.64	$3.03	($1.54)	$0.00	$7.63	$9.05	$5.99	$1.94	($2.08)
Adjusted Weighted Average Basic Shares Outstanding	93M	91.20M	89.40M	87.60M	85.20M	0.00	77.80M	74.80M	70.20M	67.20M	65.90M
Adjusted Diluted Earnings per Share	$2.56	$3.00	$1.62	$3.01	($1.53)	$0.00	$7.57	$9.00	$5.96	$1.93	($2.08)
Adjusted Weighted Average Diluted Shares Outstanding	94.30M	92M	90.10M	88.20M	85.60M	0.00	78.40M	75.20M	70.50M	67.40M	65.90M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	91.03M	89.52M	87.56M	87.03M	79.47M	0.00	153.13M	142.30M	136.34M	65.84M	64.85M
Normalized Net Operating Profit after Tax (NOPAT)	307	349	265	335	343	430	655	777	543	318	219
Normalized NOPAT Margin	8.12%	7.77%	6.98%	8.12%	8.35%	9.89%	11.20%	11.40%	8.48%	6.08%	4.08%
Pre Tax Income Margin	8.33%	8.68%	5.60%	7.54%	2.69%	10.87%	12.60%	12.53%	9.82%	3.88%	-2.53%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	12.15	14.95	8.73	6.87	2.32	7.92	11.50	9.59	6.61	2.30	-0.39
NOPAT to Interest Expense	8.77	12.28	5.95	5.67	1.70	6.35	9.38	7.70	4.50	1.64	-0.26
EBIT Less CapEx to Interest Expense	8.12	7.97	2.29	3.35	-0.65	5.26	7.79	5.75	4.16	1.21	-1.82
NOPAT Less CapEx to Interest Expense	4.74	5.30	-0.49	2.16	-1.26	3.68	5.67	3.86	2.06	0.55	-1.69
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	20.01%	20.07%	41.39%	25.56%	-56.03%	21.01%	16.67%	16.04%	26.64%	86.32%	-82.01%
Augmented Payout Ratio	69.72%	63.66%	130.19%	53.83%	-361.37%	52.75%	36.91%	82.51%	92.06%	240.05%	-140.28%

This table displays calculated financial ratios and metrics derived from Brunswick's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/30/2024	6/29/2024	9/28/2024	12/31/2024	3/29/2025	6/28/2025	9/27/2025	12/31/2025	4/4/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	64,850,982.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	64,850,982.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	0.32
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-6.16%	-13.95%	-21.71%	-15.18%	-20.10%	-15.20%	-10.49%	0.21%	6.82%	15.49%	12.79%
EBITDA Growth	-9.35%	-27.83%	-39.98%	-40.25%	-37.55%	-82.27%	-29.06%	-23.21%	-199.65%	263.75%	-3.21%
EBIT Growth	-14.94%	-41.65%	-52.98%	-19.72%	-51.86%	-141.10%	-47.92%	-35.30%	-349.33%	191.07%	-15.45%
NOPAT Growth	-25.08%	-45.36%	-30.73%	-18.31%	-52.27%	-143.51%	-53.46%	-34.70%	-354.62%	173.49%	-2.98%
Net Income Growth	-31.32%	-57.02%	-39.45%	-25.76%	-60.36%	-235.47%	-70.29%	-40.70%	-628.03%	122.67%	3.96%
EPS Growth	-26.82%	-54.59%	-36.54%	-22.11%	-58.39%	-235.96%	-69.70%	-39.86%	-635.82%	126.45%	6.67%
Operating Cash Flow Growth	20.49%	3.13%	-870.89%	0.00%	-65.99%	8.15%	82.14%	49.86%	108.31%	-56.63%	-133.94%
Free Cash Flow Firm Growth	97.22%	93.65%	69.69%	66.13%	-47.41%	293.12%	495.55%	2,254.01%	1,033.52%	961.07%	58.45%
Invested Capital Growth	4.67%	2.96%	3.98%	3.63%	3.22%	-2.21%	-6.14%	-9.52%	-18.53%	-12.62%	-10.99%
Revenue Q/Q Growth	-6.39%	-14.54%	0.23%	0.00%	-11.82%	-9.30%	5.79%	18.43%	-6.00%	-1.94%	3.32%
EBITDA Q/Q Growth	2.96%	-33.49%	-0.28%	0.00%	7.62%	-81.12%	299.06%	37.04%	-196.51%	168.92%	6.19%
EBIT Q/Q Growth	3.01%	-46.07%	1.47%	0.00%	-38.22%	-146.04%	228.57%	76.91%	-338.08%	116.82%	19.36%
NOPAT Q/Q Growth	-8.98%	-35.76%	-2.97%	0.00%	-46.82%	-158.56%	203.80%	102.02%	-307.36%	116.90%	37.05%
Net Income Q/Q Growth	-16.48%	-45.87%	11.66%	0.00%	-55.40%	-284.98%	124.48%	193.56%	-497.13%	107.94%	12.30%
EPS Q/Q Growth	-15.26%	-44.72%	11.24%	0.00%	-54.73%	-280.60%	124.79%	196.67%	-503.37%	108.91%	0.00%
Operating Cash Flow Q/Q Growth	-26.02%	42.94%	-154.15%	0.00%	0.00%	354.60%	-108.94%	1,254.01%	-55.60%	-5.34%	-148.23%
Free Cash Flow Firm Q/Q Growth	31.66%	43.61%	-200.79%	0.00%	-197.47%	173.87%	516.08%	59.11%	28.92%	-16.03%	-8.00%
Invested Capital Q/Q Growth	1.87%	-3.36%	6.90%	0.00%	1.46%	-8.44%	2.59%	-5.06%	-8.64%	-1.80%	4.50%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	27.91%	26.76%	27.37%	27.08%	26.15%	21.92%	24.87%	25.55%	25.79%	23.08%	24.93%
EBITDA Margin	17.03%	13.25%	13.19%	10.91%	13.31%	2.77%	10.45%	12.09%	-12.42%	8.73%	8.97%
Operating Margin	12.31%	7.95%	8.10%	10.96%	7.73%	-4.82%	4.61%	7.14%	-17.81%	3.14%	3.65%
EBIT Margin	12.68%	8.00%	8.10%	10.91%	7.64%	-3.88%	4.71%	7.04%	-17.84%	3.06%	3.53%
Profit (Net Income) Margin	7.06%	4.47%	4.98%	6.93%	3.50%	-7.14%	1.65%	4.10%	-17.31%	1.40%	1.52%
Tax Burden Percent	70.27%	70.98%	78.16%	75.47%	63.81%	95.82%	71.89%	78.75%	88.43%	68.75%	78.07%
Interest Burden Percent	79.22%	78.72%	78.66%	84.13%	71.84%	192.19%	48.78%	73.90%	109.77%	66.67%	55.24%
Effective Tax Rate	28.86%	17.25%	21.38%	20.91%	32.33%	0.00%	28.11%	20.85%	0.00%	31.62%	21.93%
Return on Invested Capital (ROIC)	14.33%	10.69%	9.15%	0.00%	0.00%	-4.47%	4.07%	7.18%	-16.67%	3.14%	4.15%
ROIC Less NNEP Spread (ROIC-NNEP)	12.98%	9.16%	8.26%	0.00%	0.00%	-6.68%	3.14%	6.09%	-19.90%	2.62%	3.26%
Return on Net Nonoperating Assets (RNNOA)	12.72%	8.32%	8.59%	0.00%	0.00%	-6.60%	3.50%	6.37%	-22.15%	2.84%	3.86%
Return on Equity (ROE)	27.05%	19.01%	17.74%	0.00%	0.00%	-11.07%	7.57%	13.55%	-38.83%	5.98%	8.00%
Cash Return on Invested Capital (CROIC)	9.79%	9.90%	7.29%	0.00%	0.00%	8.02%	10.69%	13.23%	17.92%	12.69%	10.77%
Operating Return on Assets (OROA)	13.74%	8.16%	7.63%	0.00%	0.00%	-3.41%	3.88%	5.89%	-16.17%	2.99%	3.43%
Return on Assets (ROA)	7.65%	4.56%	4.69%	0.00%	0.00%	-6.28%	1.36%	3.43%	-15.70%	1.37%	1.48%
Return on Common Equity (ROCE)	27.05%	19.01%	17.74%	0.00%	0.00%	-11.07%	7.57%	13.55%	-38.83%	5.98%	8.00%
Return on Equity Simple (ROE_SIMPLE)	24.03%	0.00%	18.35%	0.00%	0.00%	0.00%	4.40%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	140	90	87	125	67	-39	40	82	-170	29	39
NOPAT Margin	8.75%	6.58%	6.37%	8.67%	5.23%	-3.38%	3.31%	5.65%	-12.46%	2.15%	2.85%
Net Nonoperating Expense Percent (NNEP)	1.35%	1.53%	0.89%	1.21%	1.03%	2.21%	0.93%	1.10%	3.23%	0.52%	0.89%
Return On Investment Capital (ROIC_SIMPLE)	-	1.98%	-	-	-	-0.92%	0.93%	1.96%	-4.43%	0.77%	1.01%
Cost of Revenue to Revenue	72.09%	73.24%	72.63%	72.92%	73.85%	78.08%	75.13%	74.45%	74.21%	76.92%	75.07%
SG&A Expenses to Revenue	11.74%	14.59%	14.92%	12.59%	14.19%	15.73%	17.02%	14.97%	15.87%	15.80%	17.57%
R&D to Revenue	2.84%	3.11%	3.36%	2.98%	3.28%	3.39%	3.15%	2.89%	3.19%	3.37%	3.36%
Operating Expenses to Revenue	15.60%	18.80%	19.27%	16.12%	18.42%	26.75%	20.27%	18.41%	43.60%	19.94%	21.28%
Earnings before Interest and Taxes (EBIT)	202	109	111	158	97	-45	58	102	-243	41	49
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	271	181	180	158	170	32	128	175	-169	116	124
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.59	3.12	3.21	0.00	2.75	2.26	1.88	1.92	2.54	2.97	2.97
Price to Tangible Book Value (P/TBV)	68.95	82.87	111.39	0.00	161.32	540.23	0.00	187.25	47.28	53.89	57.55
Price to Revenue (P/Rev)	0.82	1.02	1.09	0.00	0.00	0.81	0.69	0.72	0.80	0.90	0.86
Price to Earnings (P/E)	10.79	15.51	17.47	0.00	0.00	32.80	42.79	87.77	0.00	0.00	0.00
Dividend Yield	2.02%	1.69%	1.70%	2.27%	1.96%	2.60%	3.16%	3.06%	2.69%	2.32%	2.36%
Earnings Yield	9.27%	6.45%	5.72%	0.00%	0.00%	3.05%	2.34%	1.14%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.80	2.11	2.06	0.00	1.83	1.61	1.41	1.46	1.72	1.94	1.88
Enterprise Value to Revenue (EV/Rev)	1.13	1.32	1.46	0.00	0.00	1.20	1.11	1.09	1.16	1.23	1.22
Enterprise Value to EBITDA (EV/EBITDA)	6.87	8.31	9.82	0.00	0.00	10.32	10.16	11.02	36.20	26.46	27.32
Enterprise Value to EBIT (EV/EBIT)	9.09	11.36	14.24	0.00	0.00	19.61	21.16	26.21	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	12.84	16.68	18.74	0.00	0.00	27.47	31.43	42.84	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	10.29	11.50	14.76	0.00	19.19	14.57	10.16	8.38	8.16	11.78	12.80
Enterprise Value to Free Cash Flow (EV/FCFF)	18.83	21.60	28.77	0.00	0.00	19.83	12.79	10.48	8.64	14.24	16.46
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.17	1.16	1.38	1.40	1.26	1.24	1.33	1.19	1.34	1.29	1.43
Long-Term Debt to Equity	0.95	0.95	1.16	1.18	1.17	1.11	1.12	1.10	1.28	1.11	1.13
Financial Leverage	0.98	0.91	1.04	1.01	1.04	0.99	1.11	1.05	1.11	1.08	1.18
Leverage Ratio	2.99	3.04	3.11	3.08	2.94	2.99	3.15	3.11	3.12	3.12	3.27
Compound Leverage Factor	2.37	2.39	2.45	2.59	2.11	5.75	1.54	2.30	3.42	2.08	1.81
Debt to Total Capital	53.82%	53.80%	57.97%	58.40%	55.84%	55.30%	57.02%	54.42%	57.31%	56.39%	58.91%
Short-Term Debt to Total Capital	10.08%	10.06%	9.34%	9.39%	4.32%	5.74%	8.87%	4.23%	2.50%	7.92%	12.58%
Long-Term Debt to Total Capital	43.74%	43.73%	48.64%	49.01%	51.51%	49.56%	48.15%	50.19%	54.80%	48.47%	46.34%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	46.18%	46.20%	42.03%	41.60%	44.16%	44.70%	42.98%	45.58%	42.69%	43.61%	41.09%
Debt to EBITDA	2.24	2.39	3.16	0.00	0.00	3.84	4.46	4.51	13.23	8.40	9.33
Net Debt to EBITDA	1.89	1.88	2.49	0.00	0.00	3.31	3.84	3.78	11.14	7.16	8.00
Long-Term Debt to EBITDA	1.82	1.95	2.65	0.00	0.00	3.44	3.77	4.16	12.65	7.22	7.34
Debt to NOPAT	4.19	4.81	6.02	0.00	0.00	10.23	13.79	17.54	-22.65	-73.79	-70.25
Net Debt to NOPAT	3.53	3.78	4.74	0.00	0.00	8.82	11.88	14.68	-19.07	-62.90	-60.26
Long-Term Debt to NOPAT	3.40	3.91	5.05	0.00	0.00	9.17	11.64	16.17	-21.67	-63.42	-55.25
Altman Z-Score	2.97	2.98	2.86	0.00	0.00	2.64	2.47	2.57	2.55	2.85	2.75
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.47	1.43	1.68	1.70	1.97	1.65	1.57	1.68	1.78	1.44	1.38
Quick Ratio	0.54	0.55	0.70	0.69	0.66	0.55	0.57	0.62	0.65	0.55	0.55
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-45	-25	-77	-22	-67	49	303	482	622	522	480
Operating Cash Flow to CapEx	357.76%	544.81%	-296.71%	0.00%	203.01%	1,303.83%	-79.88%	761.93%	440.13%	292.09%	-122.10%
Free Cash Flow to Firm to Interest Expense	-1.61	-0.93	-2.68	-0.69	-2.02	1.09	9.08	16.08	23.03	30.36	19.53
Operating Cash Flow to Interest Expense	7.05	10.38	-5.36	0.00	2.04	6.79	-0.82	10.54	5.20	7.73	-2.61
Operating Cash Flow Less CapEx to Interest Expense	5.08	8.47	-7.17	0.00	1.04	6.27	-1.85	9.16	4.02	5.08	-4.74
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.08	1.02	0.94	0.00	0.00	0.88	0.82	0.84	0.91	0.98	0.97
Accounts Receivable Turnover	11.76	12.36	9.16	0.00	0.00	11.36	8.71	9.80	10.45	11.27	9.26
Inventory Turnover	3.32	3.13	2.85	0.00	0.00	2.80	2.62	2.71	2.85	3.23	3.18
Fixed Asset Turnover	5.23	4.95	4.63	0.00	0.00	4.08	4.00	4.02	4.15	4.36	4.54
Accounts Payable Turnover	8.48	7.56	7.89	0.00	0.00	8.17	8.16	8.82	9.99	10.49	9.42
Days Sales Outstanding (DSO)	31.03	29.54	39.84	0.00	0.00	32.14	41.91	37.23	34.93	32.39	39.41
Days Inventory Outstanding (DIO)	109.96	116.60	127.90	0.00	0.00	130.52	139.23	134.56	127.88	112.97	114.74
Days Payable Outstanding (DPO)	43.03	48.27	46.29	0.00	0.00	44.68	44.71	41.41	36.55	34.79	38.76
Cash Conversion Cycle (CCC)	97.96	97.87	121.45	0.00	0.00	117.98	136.43	130.39	126.26	110.57	115.39
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	4,138	3,999	4,275	4,210	4,272	3,911	4,013	3,809	3,480	3,418	3,571
Invested Capital Turnover	1.64	1.62	1.44	0.00	0.00	1.32	1.23	1.27	1.34	1.46	1.46
Increase / (Decrease) in Invested Capital	185	115	164	148	133	-88	-263	-401	-791	-494	-441
Enterprise Value (EV)	7,458	8,434	8,797	0.00	7,835	6,287	5,662	5,556	6,002	6,620	6,723
Market Capitalization	5,405	6,522	6,572	0.00	5,598	4,268	3,522	3,651	4,156	4,828	4,754
Book Value per Share	$29.87	$30.33	$30.01	$29.79	$30.72	$28.68	$28.44	$29.00	$25.01	$25.00	$24.70
Tangible Book Value per Share	$1.12	$1.14	$0.86	$0.61	$0.52	$0.12	($0.16)	$0.30	$1.35	$1.38	$1.27
Total Capital	4,517	4,518	4,877	4,841	4,606	4,233	4,356	4,179	3,827	3,728	3,898
Total Debt	2,431	2,430	2,827	2,827	2,572	2,341	2,484	2,274	2,193	2,102	2,296
Total Long-Term Debt	1,976	1,976	2,372	2,372	2,373	2,098	2,098	2,098	2,097	1,807	1,806
Net Debt	2,053	1,912	2,226	2,196	2,237	2,019	2,140	1,904	1,846	1,792	1,970
Capital Expenditures (CapEx)	55	52	52	0.00	33	24	34	42	32	46	53
Debt-free, Cash-free Net Working Capital (DFCFNWC)	895	733	1,029	982	1,051	790	919	744	722	654	825
Debt-free Net Working Capital (DFNWC)	1,237	1,212	1,589	1,575	1,353	1,077	1,224	1,079	1,038	930	1,115
Net Working Capital (NWC)	782	758	1,133	1,120	1,154	834	838	902	943	635	624
Net Nonoperating Expense (NNE)	27	29	19	25	22	44	20	22	66	9.95	18
Net Nonoperating Obligations (NNO)	2,053	1,912	2,226	2,196	2,237	2,019	2,140	1,904	1,846	1,792	1,970
Total Depreciation and Amortization (D&A)	69	72	69	0.00	72	77	70	73	74	76	75
Debt-free, Cash-free Net Working Capital to Revenue	13.51%	11.44%	17.08%	0.00%	0.00%	15.08%	18.03%	14.59%	13.93%	12.20%	14.95%
Debt-free Net Working Capital to Revenue	18.69%	18.94%	26.38%	0.00%	0.00%	20.56%	24.03%	21.16%	20.03%	17.34%	20.20%
Net Working Capital to Revenue	11.81%	11.83%	18.82%	0.00%	0.00%	15.92%	16.45%	17.69%	18.18%	11.83%	11.31%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.61	$0.91	$0.99	$1.48	$0.67	($1.20)	$0.31	$0.89	($3.59)	$0.31	$0.32
Adjusted Weighted Average Basic Shares Outstanding	69.80M	70.20M	68.30M	67.60M	66.60M	67.20M	66.20M	66M	65.70M	65.90M	65.40M
Adjusted Diluted Earnings per Share	$1.61	$0.89	$0.99	$1.48	$0.67	($1.21)	$0.30	$0.89	($3.59)	$0.32	$0.32
Adjusted Weighted Average Diluted Shares Outstanding	70M	70.50M	68.50M	67.60M	66.60M	67.40M	66.30M	66M	65.70M	65.90M	65.70M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	137.63M	136.34M	67.57M	132.45M	65.98M	65.84M	65.68M	65.33M	65.04M	64.85M	64.97M
Normalized Net Operating Profit after Tax (NOPAT)	151	102	98	131	75	23	41	88	64	36	43
Normalized NOPAT Margin	9.48%	7.49%	7.15%	9.10%	5.88%	1.96%	3.38%	6.09%	4.71%	2.67%	3.12%
Pre Tax Income Margin	10.05%	6.30%	6.37%	9.18%	5.49%	-7.46%	2.30%	5.20%	-19.58%	2.04%	1.95%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	7.19	3.99	3.87	4.83	2.95	-0.99	1.72	3.40	-8.99	2.37	1.98
NOPAT to Interest Expense	4.96	3.28	3.04	3.84	2.02	-0.86	1.21	2.73	-6.28	1.67	1.60
EBIT Less CapEx to Interest Expense	5.22	2.09	2.06	0.00	1.94	-1.51	0.70	2.01	-10.17	-0.27	-0.15
NOPAT Less CapEx to Interest Expense	2.99	1.38	1.23	0.00	1.01	-1.39	0.18	1.34	-7.46	-0.98	-0.54
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	22.11%	26.64%	29.81%	0.00%	0.00%	86.32%	135.97%	269.47%	-47.09%	-82.01%	-82.86%
Augmented Payout Ratio	83.96%	92.06%	103.88%	0.00%	0.00%	240.05%	332.81%	445.19%	-78.53%	-140.28%	-134.58%

Financials Breakdown Chart

Key Financial Trends

Here are the most material, trend-focused takeaways from Brunswick (BC)’s quarterly statements over the last four years, focusing on revenue, profitability, cash flow, and leverage. Bullets are ordered with positives first, then neutral, then negatives.

Q4 2025 revenue rose to about $1.334 billion, up roughly 15% year-over-year from Q4 2024’s $1.155 billion.
Q4 2025 Consolidated Net Income Attributable to Common Shareholders was about $18.7 million, reversing Q4 2024’s loss of about $82.5 million.
Q4 2025 Basic EPS of $0.31 and Diluted EPS of $0.32 marked a positive turn from Q4 2024’s negative EPS of about $-3.59.
Q4 2025 cash from continuing operating activities was about $132.9 million, indicating solid quarterly cash generation.
Q4 2025 net cash from continuing investing activities was about $97.5 million, reflecting cash inflows from asset sales/investments in the quarter.
Q4 2025 net cash from continuing financing activities was about $313.2 million, contributing to a notable quarterly financing inflow.
Brunswick’s cash balance has hovered around $0.30 billion in 2025 (roughly $297.7M–$315.7M across recent quarters), supporting liquidity.
Leverage remains meaningful, with long-term debt around $2.0–$2.1 billion and total liabilities near $3.8–4.0 billion, indicating substantial leverage to manage.
Profitability and cash flow have shown volatility, including a Q3 2025 net loss of about $235.5 million and a negative Q1 2025 operating cash flow of about $13.4 million.
Quarterly dividend activity appears absent in the data (cash dividends per share shown as $0.00), which may affect income-oriented investors.

05/27/26 02:38 AM ETAI Generated. May Contain Errors.

Brunswick Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Brunswick's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Over the last 10 years, Brunswick's net income changed from $241.40 million in 2015 to -$137.30 million in 2025, a change of -156.9%. View Brunswick's forecast to see where analysts expect Brunswick to go next.

Brunswick's total operating income in 2025 was -$40.70 million, based on the following breakdown:

Total Gross Profit: $1.33 billion
Total Operating Expenses: $1.37 billion

Over the last 10 years, Brunswick's total revenue changed from $3.78 billion in 2015 to $5.36 billion in 2025, a change of 41.9%.

Brunswick's total liabilities were at $3.69 billion at the end of 2025, a 2.6% decrease from 2024, and a 97.0% increase since 2015.

In the past 10 years, Brunswick's cash and equivalents has ranged from $256.80 million in 2025 to $657.30 million in 2015, and is currently $256.80 million as of their latest financial filing in 2025.

Over the last 10 years, Brunswick's book value per share changed from 14.07 in 2015 to 25.00 in 2025, a change of 77.6%.

Related Companies

Financial statements for NYSE:BC last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Brunswick (BC) Financials

Financials Breakdown Chart

Key Financial Trends

Brunswick Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Brunswick (BC) Financials

Annual Income Statements for Brunswick

Quarterly Income Statements for Brunswick

Annual Cash Flow Statements for Brunswick

Quarterly Cash Flow Statements for Brunswick

Annual Balance Sheets for Brunswick

Quarterly Balance Sheets for Brunswick

Annual Metrics And Ratios for Brunswick

Quarterly Metrics And Ratios for Brunswick

Financials Breakdown Chart

Key Financial Trends

Brunswick Financials - Frequently Asked Questions

When does Brunswick's fiscal year end?

How has Brunswick's net income changed over the last 10 years?

What is Brunswick's operating income?

How has Brunswick's revenue changed over the last 10 years?

How much debt does Brunswick have?

How much cash does Brunswick have?

How has Brunswick's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools